Cellares Raises $255M Series C to Launch First Integrated Development and Manufacturing Organization (IDMO) and Pioneering Smart Factory to Meet Global Demand for Life-Saving Cell Therapies
Series C is led by Koch Disruptive Technologies and includes Bristol Myers Squibb, DFJ Growth, Willett Advisors and existing investors Eclipse, Decheng Capital, and 8VC Cellares'...
Manufacturing Tech Can Help Make Gene Therapies More Accessible
Gene therapy firms face manufacturing and regulatory challenges that slow development and limit patient access. The good news is that new technologies have the potential...